EcoDrugPlus

Cyclin-Dependent Kinase 6

Ensembl ID : ENSIPUG00000022712
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSIPUG00000019436
Gene Symbol: CDK7
2 Cross references
218 Possible Orthologues:

Cyclin-Dependent Kinase 9

Ensembl ID : ENSIPUG00000021301
Gene Symbol: LOC108279315
3 Cross references
206 Possible Orthologues:

Cyclin-Dependent Kinase 9-Like

Ensembl ID : ENSIPUG00000021318
Gene Symbol: LOC108279348
3 Cross references
206 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSIPUG00000014679
Gene Symbol: CYSLTR1
2 Cross references
172 Possible Orthologues:

Cystic Fibrosis Transmembrane Conductance Regulator-Like

Ensembl ID : ENSIPUG00000023141
Gene Symbol: LOC108264684
3 Cross references
216 Possible Orthologues:

Cytidine Deaminase A

Ensembl ID : ENSIPUG00000022850
Gene Symbol: CDAA
3 Cross references
200 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSIPUG00000023900
Gene Symbol: CDAB
3 Cross references
156 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSIPUG00000006894
Gene Symbol: LOC108273895
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30

Ensembl ID : ENSIPUG00000012663
Gene Symbol: LOC108258764
4 Cross references
572 Possible Orthologues:

Cytochrome P450 3a30

Ensembl ID : ENSIPUG00000012681
Gene Symbol: LOC108258762
4 Cross references
572 Possible Orthologues:

Cytochrome P450 3a30

Ensembl ID : ENSIPUG00000012596
Gene Symbol: LOC108258760
3 Cross references
572 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).